Before you Buy: Check the Credit Tab to Make Sure Your Jurisdiction is Accredited!
In any industry, M&A is challenging. In cannabis, the issues can be even more complex. This deeper dive panel will focus on five of the most difficult legal issues to manage in these transactions. They include: non-competes/non-solicitations, earn-out provisions, implications of cash vs. stock components in consideration, consideration dependent on future legalization efforts, and clarifying state approval processes for transactions. Join this panel to hear more about these challenging issues and the best strategies for addressing them in individual transactions.
This program is eligible for 1 hours of General CLE credit in 60-minute states, and 1.2 hours of General CLE credit in 50-minute states. Credit hours are estimated and are subject to each state’s approval and credit rounding rules.
INCBA webinars are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted. For many live events, credit approval is not received prior to the program.
INCBA on demand programs are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted.
For current accreditation status, please select your jurisdiction below.
|Cannabis M&A CLE materials 6.4.2022 (38.3 KB)||Available after Purchase|
|M&A-Cannabis.220524.02 (298 KB)||Available after Purchase|
Samantha Gleit is a partner at Feuerstein Kulick, focusing on debt and equity financing, corporate restructuring, alternative capital sources, acquisition financing, senior and mezzanine investments, and related commercial transactions. In 2021, Samantha was selected by Law360 as a “Rising Star” in the cannabis industry for top attorneys under 40 whose legal accomplishments transcend their age.
Throughout her career, Samantha has advised institutional and alternative investors on distressed debt and high risk lending. She is known for implementing tailored, regulatory-compliant, loan and workout structures designed to maximize protection in the evolving cannabis legal landscape. Samantha also has extensive experience advising companies (ranging from startups to large public companies) on debt structure, risk management, workouts, acquisition financing, capitalization and compliance. Beyond traditional legal advice, Samantha also assists startups and growing companies identify liquidity sources, develop growth strategies and negotiate efficient financing solutions.
Recent representations include GlassHouse; Jushi; Holistic; Loudpack; lenders to Curaleaf, Terrascend, and Cresco; cannabis-focused REITs, a private lender in a $250 million senior secured credit facility with the factoring arm of a wholesale B2B marketplace; Navy Capital in leading in a private placement of convertible debt with 4Front; and FocusGrowth Capital Partners on debt and equity financings with various multi-state and single state operators.
Samantha is regularly interviewed and published in leading debt media outlets. In addition to being selected as a top cannabis lawyer under 40 in 2021 by Law360, Samantha was selected as a Rising Star in the 2015 – 2021 editions of New York Metro Super Lawyers® and featured in The New York Times Magazine Super Lawyers® Top Women Attorneys in the New York Metro Area. Samantha is regularly interviewed by legal publications on debt and equity financing in the cannabis industry. She has also co-authored an article featured on the cover of the ABI Journal discussing suggested reforms to the federal bankruptcy process. In 2013, Samantha was awarded the International Bar Association’s Insolvency Scholarship for her award winning article on distressed law firms. Prior to joining Feuerstein Kulick, Samantha worked at King & Spalding LLP in New York, in the corporate finance and investments group.
One of the leading corporate cannabis lawyers in the USA, having participated in over $2 Billion of cannabis industry financing, M&A and other transactions.
Neil M. Kaufman is the managing member of Kaufman McGowan PLLC, Long Island’s Corporate & Securities Law Firm ™ and Corporate & Securities Counsel to the Cannabis Industry™. He is one of the leading corporate cannabis lawyers in New York and the USA and a fixture of the New York and Long Island corporate and securities legal community.
Mr. Kaufman represents emerging growth, middle market and public companies and investment firms in their corporate, securities, financing, borrowing, merger & acquisition and other legal matters. Mr. Kaufman is particularly well known for advising clients with respect to SEC regulation, public offerings, private placements and mergers & acquisitions, as well as all types of commercial contracts. He is a frequent speaker on corporate, securities and cannabis law topics, and is an approved Vistage speaker on mergers & acquisitions.
Daniel Haymann specializes in corporate and commercial law. Based on his extensive business experience, he has a good feel for new markets and understands the requirements of go-to-market and scale-up strategies. As an interdisciplinary and hands-on advisor, his focus is on investments, venture capital and financing transactions as well as regulatory issues in the healthcare and consumer goods sectors.
He advises investors, start-ups and vertically integrated companies along the value chain, including on regulatory issues relating to THC, CBD and other cannabinoids and psychoactive substances, GMP and GDP standards, food and cosmetics regulations and approval procedures before Swissmedic, the Swiss remedy institute.
Daniel is co-founder and co-chair of the European branch of the International Cannabis Bar Association (INCBA Europe). As a Swiss-Israeli dual citizen, he also focuses on serving clients with connections to Israel and strengthening the relevant business relationships.
Prior to his career as a lawyer, Daniel spent over 10 years in senior positions as a commodity trader for multinational corporations.